Sign up to save your podcasts
Or
Share Immune checkpoint inhibitors in prostate cancer: Current and future practice
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Immune checkpoint inhibitors in prostate cancer: Current and future practice
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts consider the current role of immune checkpoint inhibitors in prostate cancer and possible future directions.
The experts
- Prof. Karim Fizazi - Gustave Roussy, Villejuif, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck Sharp & Dohme Corp. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/icis-prostate-cancer/
View all episodes
By touchpodcasttouchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts consider the current role of immune checkpoint inhibitors in prostate cancer and possible future directions.
The experts
- Prof. Karim Fizazi - Gustave Roussy, Villejuif, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck Sharp & Dohme Corp. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/icis-prostate-cancer/